Clinical Trials Directory

Trials / Terminated

TerminatedNCT03277989

INFINITY™Total Ankle Replacement Follow-up

Status
Terminated
Phase
Study type
Observational
Enrollment
155 (actual)
Sponsor
Stryker Trauma and Extremities · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Study Title INFINITY™Total Ankle Replacement Follow-up (ITAR) Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY™ Total Ankle System Number of Subjects 150 with 9 sites

Detailed description

The primary outcome measure of this post-market clinical observational study is to collect data relating to the INFINITY™ Total Ankle System survivorship at 10 years. The secondary outcome measures are to characterize the improvements after implantation over a 10 year period using patient reported outcome measures related to quality of life, pain and functional improvements, safety of the implants, as well as radiographic assessments (X-Rays) The outcome measures collected in this study will be analyzed and reported as required for local, regional, and country requirements (i.e., regulatory authorities and notified bodies).

Conditions

Timeline

Start date
2017-10-09
Primary completion
2023-03-31
Completion
2023-03-31
First posted
2017-09-11
Last updated
2025-02-14
Results posted
2025-02-14

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03277989. Inclusion in this directory is not an endorsement.